← Eichor
Condition: Hpv Related Squamous Cell Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hpv Related Squamous Cell Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04988074The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07060261A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
Phase 2 · 1 location(s) · Nader Sadeghi · NCT04277858The Minimalist Trial-2
Phase 2 · 3 location(s) · Washington University School of Medicine · NCT06702033A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Canc
Phase 3 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT06563479Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06345287E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radi
NA · 1 location(s) · Emory University · NCT06662058ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Phase 2 · 2 location(s) · Jennifer Dorth · NCT07425054Detecting HPV DNA in Anal and Cervical Cancers
Phase N/A · 2 location(s) · University of Chicago · NCT04857528E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
NA · 1 location(s) · Dr. Danielle Vicus · NCT03061435Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Phase 2 · 2 location(s) · Jonathan Schoenfeld, MD, MPH · NCT04900623Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Phase 2 · 2 location(s) · Emory University · NCT06636734A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Phase 1/Phase 2 · 4 location(s) · Theravectys S.A. · NCT06319963Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas
Phase N/A · 1 location(s) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Banglade · NCT06642324Screening Strategies Among High-risk Populations for Anal Cancer
NA · 4 location(s) · Lisa Flowers · NCT06628570
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.